These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36994686)

  • 1. Initial clinical, laboratory and radiological features of SARS-CoV-2-infected patients and their impact on the course of the disease.
    Maligłówka M; Bułdak Ł; Cyrnek M; Hachuła M; Kosowski M; Basiak M; Szkróbka W; Bosowska J; Cebula M; Holecki M; Okopień B
    Adv Clin Exp Med; 2023 Oct; 32(10):1125-1132. PubMed ID: 36994686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal changes in laboratory markers of survivors and non-survivors of adult inpatients with COVID-19.
    Ouyang SM; Zhu HQ; Xie YN; Zou ZS; Zuo HM; Rao YW; Liu XY; Zhong B; Chen X
    BMC Infect Dis; 2020 Dec; 20(1):952. PubMed ID: 33308159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.
    Lyngbakken MN; Berdal JE; Eskesen A; Kvale D; Olsen IC; Rangberg A; Jonassen CM; Omland T; Røsjø H; Dalgard O
    Trials; 2020 Jun; 21(1):485. PubMed ID: 32503662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiparametric correlation of laboratory biomarkers to multiorgan failure outcome in hospitalized COVID-19 patients: a retrospective observational study.
    Ballini A; Cantore S; Serretiello E; Troiano G; Smimmo A; Dioguardi M; Spirito F; Sasso FC; De Vito D; Lo Muzio L; Di Domenico M
    Eur Rev Med Pharmacol Sci; 2023 Sep; 27(18):8962-8974. PubMed ID: 37782206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors of a severe course of pediatric multi-system inflammatory syndrome temporally associated with COVID-19.
    Stasiak A; Perdas E; Smolewska E
    Eur J Pediatr; 2022 Oct; 181(10):3733-3738. PubMed ID: 35948653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical features and risk factors for secondary hemophagocytic lymphohistiocytosis in elderly patients with severe SARS-CoV-2 infection: a multicenter retrospective cohort study].
    Deng Y; Lu S; Zhang G; Sun W; Chu Y; Meng M; Cui Y; Li P
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Aug; 35(8):793-799. PubMed ID: 37593855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics of 182 pediatric COVID-19 patients with different severities and allergic status.
    Du H; Dong X; Zhang JJ; Cao YY; Akdis M; Huang PQ; Chen HW; Li Y; Liu GH; Akdis CA; Lu XX; Gao YD
    Allergy; 2021 Feb; 76(2):510-532. PubMed ID: 32524611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics on admission predict in-hospital fatal outcome in patients aged ≥75 years with novel coronavirus disease (COVID-19): a retrospective cohort study.
    Yu Z; Ke Y; Xie J; Yu H; Zhu W; He L; Zheng Q; Li C; Lu J; Li S; Wen S; Wei S; Liu N; Wei L; Bai R
    BMC Geriatr; 2020 Nov; 20(1):514. PubMed ID: 33256640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.
    Zhou F; Yu T; Du R; Fan G; Liu Y; Liu Z; Xiang J; Wang Y; Song B; Gu X; Guan L; Wei Y; Li H; Wu X; Xu J; Tu S; Zhang Y; Chen H; Cao B
    Lancet; 2020 Mar; 395(10229):1054-1062. PubMed ID: 32171076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive role of clinical features in patients with coronavirus disease 2019 for severe disease.
    Mo J; Liu J; Wu S; LÜ A; Xiao L; Chen D; Zhou Y; Liang L; Liu X; Zhao J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):536-541. PubMed ID: 32879103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low Vitamin D Status at Admission as a Risk Factor for Poor Survival in Hospitalized Patients With COVID-19: An Italian Retrospective Study.
    Infante M; Buoso A; Pieri M; Lupisella S; Nuccetelli M; Bernardini S; Fabbri A; Iannetta M; Andreoni M; Colizzi V; Morello M
    J Am Nutr Assoc; 2022; 41(3):250-265. PubMed ID: 33600292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New York Inner City Hospital COVID-19 Experience and Current Data: Retrospective Analysis at the Epicenter of the American Coronavirus Outbreak.
    Mani VR; Kalabin A; Valdivieso SC; Murray-Ramcharan M; Donaldson B
    J Med Internet Res; 2020 Sep; 22(9):e20548. PubMed ID: 32540837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 Viremia is Associated With Inflammatory, But Not Cardiovascular Biomarkers, in Patients Hospitalized for COVID-19.
    Myhre PL; Prebensen C; Jonassen CM; Berdal JE; Omland T
    J Am Heart Assoc; 2021 May; 10(9):e019756. PubMed ID: 33596668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Characteristics Predicting Mortality Risk in Hospitalized Geriatric Patients with COVID-19 Pneumonia: a Retrospective Study.
    Gulec-Balbay E; Altundal MMB; Kaypak MK; Cangur S; Kaya S
    Clin Lab; 2022 Aug; 68(8):. PubMed ID: 35975503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality predictors of hospitalized patients with COVID-19: Retrospective cohort study from Nur-Sultan, Kazakhstan.
    Pya Y; Bekbossynova M; Gaipov A; Lesbekov T; Kapyshev T; Kuanyshbek A; Tauekelova A; Litvinova L; Sailybayeva A; Vakhrushev I; Sarria-Santamera A
    PLoS One; 2021; 16(12):e0261272. PubMed ID: 34936681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of concomitant cardiovascular diseases and cardiac biomarkers for predicting mortality in critical COVID-19 patients.
    Aladağ N; Atabey RD
    Acta Cardiol; 2021 Apr; 76(2):132-139. PubMed ID: 32883169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical and laboratory characteristics of 215 cases of coronavirus disease 2019 with different prognosis].
    Zhu M; Zhu Y; Guo F; Zhang J; Liu W; Hou W
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Dec; 32(12):1428-1433. PubMed ID: 33541492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.